Prevalence and determinants of antidepressant non-adherence among patients with major depressive disorder in Ethiopia: a multi-center cross sectional study
Open Access
- 14 August 2025
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 29775
Abstract
Non-adherence to antidepressant medication is a well-established factor contributing to treatment failure among patients with major depressive disorder. Addressing this issue is crucial not only for enhancing individual patient outcomes but also for alleviating the broader public health burden. The study aimed to assess antidepressant medication non-adherence and its determinants among patients with major depressive disorder at public hospital psychiatric clinics in Ethiopia. Between June 12, 2024, and November 13, 2024, a multicenter cross-sectional study was conducted at public hospital psychiatric clinics in Ethiopia. Antidepressant non-adherence was assessed using a self-reported tablet count tool with pharmacy refill records available in patients’ charts at the time of the interview. The severity of adverse drug reactions (ADRs) was evaluated using the Antidepressant Side-Effect Checklist (ASEC), while the Naranjo ADR Probability Scale was employed to determine the likelihood of ADRs. Data analysis was performed using SPSS version 26.0. Frequencies and percentages, were used to describe the characteristics of study participants. For factors associated with antidepressant non-adherence, multivariate logistic regression was conducted. The association between explanatory variable and non-adherence was assessed using odds ratios (ORs) with 95% CIs. The prevalence of antidepressant medication non-adherence was 139 (32.9%). Female gender [AOR = 3.29, 95% CI (2.04, 5.31)], illiteracy [AOR = 2.17, 95% CI (1.35, 3.50)], unemployment [AOR = 3.40, 95% CI (2.15, 5.38)], treatment duration greater than 25 months [AOR = 1.89, 95% CI (1.05, 3.41)], and severe ADRs [AOR = 3.94, 95% CI (1.68, 9.23)] were significantly associated with Antidepressant medication non-adherence. Being female, illiterate, unemployed, having a treatment duration of more than 25 months, and experiencing severe adverse drug reactions were significantly associated with non-adherence. These findings highlight the need for targeted interventions to improve adherence among these high-risk groups.Keywords
This publication has 38 references indexed in Scilit:
- Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactionsJournal of Family Medicine and Primary Care, 2021
- Gender-related influences on adherence to advice and treatment-seeking guidance for infants and young children post-hospital discharge in BangladeshInternational Journal for Equity in Health, 2021
- DepressionThe Lancet, 2018
- Clinical Practice Guidelines for the management of DepressionIndian Journal of Psychiatry, 2017
- Depression among Ethiopian Adults: Cross-Sectional StudyPsychiatry Journal, 2016
- Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient settingInternational Journal of Clinical and Health Psychology, 2015
- Adherence to Antidepressant Combinations and Monotherapy for Major Depressive DisorderJournal of Psychiatric Practice, 2014
- Emerging drugs for major depressive disorderExpert Opinion on Emerging Drugs, 2012
- Selective Serotonin Reuptake Inhibitor DiscontinuationJournal of Clinical Psychopharmacology, 2007
- Predictors of Self-Reported Antidepressant AdherenceBehavioral Medicine, 2007